SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk

SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk

The coronavirus disease 2019 (COVID-19) pandemic has caused over 600,000,000 infections globally thus far. Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain...

Full description

Bibliographic Details
Main Authors: Ryan Green, Karthick Mayilsamy, Andrew R. McGill, Taylor E. Martinez, Bala Chandran, Laura J. Blair, Paula C. Bickford, Shyam S. Mohapatra, Subhra Mohapatra
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
SARS CoV-2
COVID-19
Alzheimer’s disease
neuroinflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122001322

Internet

http://www.sciencedirect.com/science/article/pii/S2329050122001322

Similar Items